Presenter Classification
Graduate Student
Presentation Type
Poster Presentation
Publication Date
4-22-2026
Start Date
22-4-2026 1:50 PM
End Date
22-4-2026 2:20 PM
Keywords
Type 2 diabetes, GLP-1 receptor agonists, Clinical decisions support, Obesity, Primary care, and Quality improvement
Abstract Type
Quality Improvement/Process Improvement Project
Abstract
Title: Improving GLP-1 RA Initiation in Primary Care Through a Paper-Based Clinical Decision Support Tool
Authors: Carissa R. Bowery, MSN, FNP-C; East Tennessee State University College of Nursing. Karen M. Carver, PhD, APRN, FNP-C; East Tennessee State University College of Nursing
This quality improvement project focuses on improving evidence-based pharmacologic management of adults with type 2 diabetes mellitus (T2DM) and obesity through implementation of a paper-based clinical decision support (CDS) tool in primary care. The aim is to increase initiation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among eligible patients and improve provider adherence to current clinical guidelines.
Processes: This project will be conducted in a rural primary care clinic using a convenience sample of adults aged 18–75 years with T2DM and body mass index ≥30 not currently prescribed a GLP-1 RA. During an 8-week implementation period, medical assistants will identify eligible patients during triage and provide a standardized paper CDS prompt to providers. Providers will document acceptance or deferral and reasons for decisions. Data will be collected via de-identified paper forms and analyzed using descriptive statistics, with potential pre/post comparison. Institutional Review Board review is anticipated to qualify as non-human subjects research. Results are expected to demonstrate increased rates of GLP-1 RA initiation, improved provider awareness, and identification of key prescribing barriers such as cost and patient preference. Limitations include short implementation duration, small sample size, reliance on manual workflow, and potential provider variability. This low-cost, scalable intervention has potential to improve guideline adherence, reduce treatment gaps, and enhance cardiometabolic outcomes, particularly in underserved rural populations, supporting its relevance to nursing practice and primary care quality improvement. Type 2 diabetes, obesity, GLP-1 receptor agonists, clinical decision support, primary care, quality improvement, evidence-based practice, rural health, prescribing behavior
Included in
Amino Acids, Peptides, and Proteins Commons, Endocrine System Diseases Commons, Investigative Techniques Commons, Public Health and Community Nursing Commons, Rural Health Commons
Improving GLP-1 RA Initiation in Primary Care Through a Paper-Based Clinical Decision Support Tool
Title: Improving GLP-1 RA Initiation in Primary Care Through a Paper-Based Clinical Decision Support Tool
Authors: Carissa R. Bowery, MSN, FNP-C; East Tennessee State University College of Nursing. Karen M. Carver, PhD, APRN, FNP-C; East Tennessee State University College of Nursing
This quality improvement project focuses on improving evidence-based pharmacologic management of adults with type 2 diabetes mellitus (T2DM) and obesity through implementation of a paper-based clinical decision support (CDS) tool in primary care. The aim is to increase initiation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among eligible patients and improve provider adherence to current clinical guidelines.
Processes: This project will be conducted in a rural primary care clinic using a convenience sample of adults aged 18–75 years with T2DM and body mass index ≥30 not currently prescribed a GLP-1 RA. During an 8-week implementation period, medical assistants will identify eligible patients during triage and provide a standardized paper CDS prompt to providers. Providers will document acceptance or deferral and reasons for decisions. Data will be collected via de-identified paper forms and analyzed using descriptive statistics, with potential pre/post comparison. Institutional Review Board review is anticipated to qualify as non-human subjects research. Results are expected to demonstrate increased rates of GLP-1 RA initiation, improved provider awareness, and identification of key prescribing barriers such as cost and patient preference. Limitations include short implementation duration, small sample size, reliance on manual workflow, and potential provider variability. This low-cost, scalable intervention has potential to improve guideline adherence, reduce treatment gaps, and enhance cardiometabolic outcomes, particularly in underserved rural populations, supporting its relevance to nursing practice and primary care quality improvement. Type 2 diabetes, obesity, GLP-1 receptor agonists, clinical decision support, primary care, quality improvement, evidence-based practice, rural health, prescribing behavior
